WO2022157015A1 - Monitoring of treatment history and the adaptation thereof - Google Patents

Monitoring of treatment history and the adaptation thereof Download PDF

Info

Publication number
WO2022157015A1
WO2022157015A1 PCT/EP2022/050234 EP2022050234W WO2022157015A1 WO 2022157015 A1 WO2022157015 A1 WO 2022157015A1 EP 2022050234 W EP2022050234 W EP 2022050234W WO 2022157015 A1 WO2022157015 A1 WO 2022157015A1
Authority
WO
WIPO (PCT)
Prior art keywords
setting
interest
physiognomic
processing unit
supply signal
Prior art date
Application number
PCT/EP2022/050234
Other languages
French (fr)
Inventor
Grégoire CHARRAUD
Matthieu JACOB
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2022157015A1 publication Critical patent/WO2022157015A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/44—Applying ionised fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0204—Operational features of power management
    • A61B2560/0214—Operational features of power management of power generation or supply
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers

Definitions

  • the invention particularly relates to a system for treating element(s) of interest of the skin of a user, in particular acne pimple(s), using atmospheric-pressure plasma.
  • Atmospheric-pressure plasma also known as “cold plasma” or by the expression “non-thermal plasma” can interact with biological tissues and cells.
  • atmospheric-pressure plasma can be used in biology and medicine for sterilization, disinfection, decontamination and wound healing.
  • atmospheric plasma treatment apparatuses are known that are configured to meet these various applications.
  • some of these apparatuses are configured for cosmetic treatment of the skin using atmospheric-pressure plasma.
  • Such apparatuses are therefore configured to apply a plasma to the surface of the skin, and in particular to the surface of the face, for acne treatment, for example.
  • Such apparatuses comprise an atmospheric-pressure plasma generation device configured to be able to generate atmospheric-pressure plasma from an electrical control signal.
  • Such cosmetic skin treatment apparatuses are generally configured to allow only one or two settings for the amount of plasma that can be instantaneously generated by the plasma generation device.
  • the setting is enabled by at least one push button or thumb wheel provided on the apparatus.
  • a setting for the amount of plasma in a treatment varies between users.
  • a setting can be optimized for one user but not for other users.
  • the aim of the invention is to overcome these disadvantages.
  • the invention relates to a system comprising:
  • control device configured to control the plasma generation device using a supply signal in accordance with a setting for performing a treatment on an element of interest of the skin, for example, an acne pimple;
  • a processing unit configured to: o temporally monitor the results of the treatment on the element of interest; o define the setting of the supply signal as a function of the results of the temporal monitoring; o transmit the defined setting of the supply signal to the control device.
  • Setting the supply signal allows the plasma generation by the generation device to be set.
  • setting the supply signal allows a total duration, a frequency and a power of this supply signal to be defined.
  • Such a system allows the setting of the supply signal to be adapted as a function of the results obtained by the treatment over time.
  • an initial setting of the supply signal can be predefined or even randomly selected.
  • This initial setting may not be the most suitable setting for treating the element of interest of the skin of the user.
  • the supply signal is set as a function of the results that are obtained during the treatment on the skin of the user.
  • the processing unit for performing the temporal monitoring is configured to: - obtain physiognomic data of the element of interest with which a temporal indication is associated; then
  • the physiognomic data comprises dimensions of the element of interest and/or a level of inflammation of the element of interest and/or a level of sebum retention.
  • the processing unit is configured to compare, each time physiognomic data is obtained, these latest obtained physiognomic data with previously obtained physiognomic data, for example, with the penultimate obtained physiognomic data, so as to compute a progression gradient for the treatment.
  • the progression gradient for the treatment allows the effectiveness of the setting that is used to be assessed.
  • the processing unit is configured to associate a progression gradient with each setting that is used, which progression gradient is computed after this setting has been used, and to store this setting and the associated progression gradient in the memory.
  • the processing unit is configured to increase the setting of the supply signal when the progression gradient is below a predefined threshold.
  • the processing unit is configured to define the setting associated with the highest progression gradient as the optimized setting.
  • the physiognomic data of the element of interest can be directly entered by the user.
  • the system also comprises an image acquisition device configured to acquire several images of the element of interest for temporally monitoring the results of the treatment on this element of interest.
  • the processing unit is then configured to obtain said physiognomic data by extracting these physiognomic data from the acquired images.
  • Extracting physiognomic data from images of the element of interest makes it easier for the user to use the system. Indeed, the user does not have to enter these physiognomic data themselves, which can be difficult for the user to measure.
  • the system comprises:
  • - a multifunction telephone comprising the image acquisition device, the processing unit and said memory; - a processing apparatus comprising the control device and the plasma generation device.
  • the multifunction telephone comprises a transmitter configured to send the adapted setting of the supply signal to a receiver of the processing apparatus via a wireless transmission.
  • the transmitter of the multifunction telephone is configured to send the adapted setting of the supply signal to the receiver of the treatment apparatus in accordance with the Bluetooth® communication standard.
  • the invention also relates to a method for setting a plasma generation device for treating an element of interest of the skin of a user, comprising:
  • the temporal monitoring comprises obtaining physiognomic data of the element of interest with which a temporal indication is associated.
  • the physiognomic data comprises dimensions of the element of interest and/or an inflammation level of the element of interest and/or a level of sebum retention.
  • the temporal monitoring comprises, each time physiognomic data is obtained, a computation of a progression gradient of the treatment on the basis of a comparison of the last physiognomic data obtained with previously obtained physiognomic data.
  • each setting that is used is associated with a progression gradient computed after this setting has been used.
  • the setting of the supply signal is increased when the progression gradient is below a predefined threshold.
  • the method comprises defining an optimized setting, with the optimized setting being the setting associated with the highest progression gradient.
  • obtaining physiognomic data of the element of interest comprises:
  • the invention also relates to a method for setting a supply signal delivered by the control device of a system as described above, in particular for treating an element of interest of the skin of a user, the method comprising: o temporally monitoring the results of the treatment on the element of interest using the processing unit; o defining the setting of the supply signal as a function of the results of the temporal monitoring using the processing unit; o transmitting the defined setting of the supply signal to the control device using the processing unit.
  • the invention also relates to a computer program product comprising instructions which, when the program is executed by a processing unit, cause the processing unit to implement a method as described above.
  • FIG 2 schematically show embodiments and implementations of the invention.
  • Figure 1 schematically shows a system SYS according to one embodiment of the invention.
  • the system SYS comprises a multifunction telephone TEL and a treatment apparatus APT, in this case cosmetic treatment.
  • Such a system SYS is configured to treat elements of interest of the skin of a user that are sensitive to atmospheric-pressure plasma.
  • the elements of interest of the skin of a user can be contemplated.
  • the elements of interest of the skin can be rashes, pore size, micro-injuries or even dark spots.
  • the cosmetic treatment apparatus APT comprises an atmospheric-pressure plasma generation device DGP.
  • the atmospheric-pressure plasma generation device DGP is configured to produce atmospheric-pressure plasma outside the apparatus APT from a supply signal SA.
  • the atmospheric-pressure plasma generation device DGP conventionally comprises a live electrode and a ground electrode, as well as a dielectric barrier placed against the live electrode.
  • the ground electrode is the biological surface on which the plasma generation device is applied. This biological surface thus acts as a floating ground electrode. An atmospheric- pressure plasma can be generated between these two electrodes.
  • a plasma is generated from a plasma gas located between the electrodes.
  • the gas is the ambient air located between the dielectric barrier and the floating ground electrode (the treated biological surface).
  • the plasma gas can contain at least one noble gas, such as helium or argon or neon.
  • the cosmetic treatment apparatus APT further comprises a control device DC configured to deliver the supply signal SA to the plasma generation device DGP.
  • control device DC is adapted to deliver the supply signal SA from the energy stored in a battery BAT of the cosmetic treatment apparatus APT.
  • the supply signal SA delivered to the plasma generation device DGP allows the control device DC to control the amount of plasma instantaneously generated by this plasma generation device DGP.
  • the supply signal SA is a pulse width modulation (PWM) signal.
  • PWM pulse width modulation
  • the amount of plasma that is instantaneously generated can then vary as a function of a duty cycle of the supply signal SA.
  • control device DC has an input configured to receive a setting RSA of the supply signal.
  • the control device DC is then configured to produce different supply signals SA depending on the setting RSA that it receives as input.
  • the setting of the supply signal allows a total duration, a frequency and a power of this supply signal to be defined.
  • control device DC can be configured to modify the duty cycle of the supply signal SA according to the setting RSA that it receives as input.
  • control device DC can be configured to modify the voltage amplitude of the supply signal SA according to the setting RSA that it receives as input.
  • the apparatus APT has a receiver RE configured to be able to receive a setting RSA of the supply signal that is transmitted by a transmitter EM of the multifunction telephone.
  • the receiver RE is electrically connected to the control device DC so as to be able to transmit the setting RSA of the supply signal thereto.
  • the setting RSA can be sent to the receiver RE by the transmitter EM using a wireless transmission RAD, for example, using the Bluetooth® communication standard.
  • the multifunction telephone TEL is configured to determine a setting RSA of the supply signal that is adapted to allow an amount of plasma to be generated that is suitable for treating an acne pimple of a user.
  • the multifunction telephone TEL comprises a processing unit UT.
  • the processing unit UT can be a processor or a microprocessor, for example.
  • the multifunction telephone TEL also comprises a memory MEM.
  • the processing unit UT is configured to temporally monitor the results of a treatment of an acne pimple ACN.
  • the processing unit UT is configured to perform this temporal monitoring on the basis of images of the acne pimple ACN acquired over time during the treatment.
  • the multifunction telephone TEL comprises an image acquisition device DA.
  • the image acquisition device DA conventionally can be a camera integrated in the multifunction telephone TEL.
  • the image acquisition device DA is therefore adapted to be able to acquire several images of an acne pimple over time during a treatment.
  • an image of the acne pimple can be acquired regularly, for example, on a daily basis.
  • the processing unit UT is configured to extract physiognomic data of the acne pimple from an acquired image of the acne pimple.
  • the physiognomic data of the acne pimple can be dimensions of the acne pimple and/or a level of inflammation and/or a level of sebum retention.
  • the physiognomic data of the acne pimple can also include an indication of the position of the acne pimple on the face, and a date of appearance of the acne pimple.
  • the physiognomic data extracted from an image are associated with a temporal indication relating to an acquisition time of the image.
  • the temporal indication can be a date of acquisition of the image.
  • the processing unit UT is also configured to store the extracted physiognomic data and its temporal indication in the memory MEM.
  • the processing unit UT is configured to compare, each time physiognomic data is extracted, the physiognomic data extracted from the last acquired image with the physiognomic data extracted from a previously acquired image, for example, the penultimate acquired image.
  • the processing unit UT is configured to compute a progression gradient of the treatment on the basis of the comparison undertaken between the physiognomic data.
  • This progression gradient of the treatment allows the effectiveness of the setting that is used to be assessed.
  • the processing unit UT is configured to adapt a setting of the supply signal for the control device DC.
  • the processing unit UT can be configured to adapt the setting of the supply signal on the basis of a comparison between the obtained progression gradient and a predefined threshold.
  • the processing unit UT can be configured to adapt the setting of the supply signal on the basis of a comparison between the obtained progression gradient and a progression gradient computed after the acquisition of the penultimate image.
  • the processing unit UT is configured to set a voltage amplitude of the supply signal delivered to the plasma generation device DGP.
  • the processing unit can also set a frequency of the supply signal.
  • the processing unit UT can also set a duty cycle of the supply signal, particularly when this supply signal is a PWM signal.
  • the processing unit UT is configured to transmit this setting to the transmitter EM in order to send the setting to the processing apparatus.
  • the setting is transmitted to the control device DC.
  • the control device DC is then configured to supply the plasma generation device DGP from a supply signal generated according to the received setting.
  • the processing unit UT is configured to store the progression gradients that are obtained for the various selected settings in the memory MEM. On the basis of the various progression gradients stored in the memory MEM, the processing unit UT is configured to define an optimized setting of the supply signal.
  • the optimized setting is the setting for which the progression gradient obtained from this setting is the highest.
  • Figure 2 describes a method for setting a supply signal delivered by the control device DC of the system described above for treating an acne pimple of a user.
  • the method comprises a first step 20, in which a first image of the acne pimple is acquired at the start of the treatment by the image acquisition device.
  • the method comprises a step 21, in which the processing unit UT extracts physiognomic data of the acne pimple from the acquired first image.
  • This information can be pimple dimensions, a level of inflammation level and a level of sebum retention.
  • a temporal indication of the acquisition time of the image is associated with these physiognomic data.
  • the physiognomic data and their temporal indications are stored in the memory MEM.
  • the method comprises a step 22, in which the processing unit UT defines an initial setting of the supply signal.
  • This setting can be a predefined setting or can be randomly selected.
  • the method comprises a series of steps 23 to 29, which it regularly repeats in order to adapt the setting of the supply signal during the treatment.
  • the method comprises temporal monitoring ST of the treatment of the acne pimple on the basis of the images acquired at various times of the treatment, for example, every day.
  • the temporal monitoring ST comprises a step 23, in which the image acquisition device acquires a new image.
  • the temporal monitoring comprises a step 24, in which the processing unit UT obtains the image acquired by the image acquisition device. This image thus has been acquired at a given time of the treatment.
  • the temporal monitoring subsequently comprises a step 25, in which the processing unit UT extracts new physiognomic data of the acne pimple from the image acquired in step 23. A temporal indication of the time of image acquisition is associated with these new physiognomic data. The new physiognomic data and their temporal indications are stored in the memory MEM.
  • the temporal monitoring comprises a step 26, in which the processing unit UT compares the physiognomic data extracted from the last acquired image with the physiognomic data extracted from the penultimate acquired image.
  • This comparison allows the processing unit UT to compute a progression gradient of the treatment.
  • This progression gradient can be computed from a difference between the levels of inflammation extracted from the two images and/or a difference between the levels of sebum retention extracted from the two images and/or a difference between the dimensions of the pimple extracted from the two images.
  • the progression gradient of the treatment allows the effectiveness of a used setting to be assessed.
  • the processing unit UT uses this progression gradient to adapt the setting of the supply signal.
  • the setting of the supply signal allows a total duration, a frequency and a power of this supply signal to be defined.
  • step 27 the processing unit UT compares the progression gradient computed in step 26 to a predefined threshold or even to a previous progression gradient computed after the acquisition of the penultimate image.
  • the processing unit UT increases, reduces or maintains the setting of the supply signal.
  • the processing unit UT can decide to maintain the setting of the supply signal or even to decrease it.
  • the processing unit UT can decide to increase the setting of the supply signal.
  • step 28 the processing unit UT transmits the adapted setting, via the transmitter EM, to the treatment device, and more specifically to the control device DC, by means of the receiver RE.
  • the processing unit assesses, in step 29, whether or not the treatment of the acne pimple has been completed. If the treatment is not complete, steps 23 to 29 are repeated.
  • the method can comprise a step 30, in which the processing unit UT defines an optimized setting of the supply signal.
  • This optimized setting is the setting that allowed the highest progression gradient to be obtained during the treatment.
  • the processing unit UT can be configured to perform temporal monitoring of several acne pimples of the user.
  • the image acquisition device can be used to take an image of several acne pimples, in particular on the face of the user.
  • the processing unit UT then can be configured to identify a position on the face for each acne pimple.
  • the processing unit UT thus can, for each acne pimple, associate and then store an identifier of the acne pimple, its position and its physiognomic data in the memory MEM.
  • the processing unit UT thus can temporally monitor each pimple separately on the basis of this information that is stored in the memory. Furthermore, the present invention is compatible with the invention that is the subject matter of the French patent application filed under No. 2009662 and/or with the invention that is the subject matter of the French patent application filed under No. 2009661.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Plasma Technology (AREA)
  • Cosmetics (AREA)

Abstract

A system is proposed comprising: - an atmospheric-pressure plasma generation device (DGP); - a control device (DC) configured to control the plasma generation device (DGP) using a supply signal in accordance with a setting for performing a treatment on an element of interest of the skin; - a processing unit (UT) configured to: o temporally monitor the results of the treatment on the element of interest; o define the setting of the supply signal as a function of the results of the temporal monitoring; o transmit the defined setting of the supply signal to the control device (DC).

Description

DESCRIPTION
TITLE: MONITORING OF TREATMENT HISTORY AND THE ADAPTATION THEREOF
The invention particularly relates to a system for treating element(s) of interest of the skin of a user, in particular acne pimple(s), using atmospheric-pressure plasma.
Atmospheric-pressure plasma (also known as “cold plasma” or by the expression “non-thermal plasma”) can interact with biological tissues and cells.
Among the possible applications, atmospheric-pressure plasma can be used in biology and medicine for sterilization, disinfection, decontamination and wound healing.
Thus, atmospheric plasma treatment apparatuses are known that are configured to meet these various applications.
In particular, some of these apparatuses are configured for cosmetic treatment of the skin using atmospheric-pressure plasma.
Such apparatuses are therefore configured to apply a plasma to the surface of the skin, and in particular to the surface of the face, for acne treatment, for example.
For example, the US patent application published under number US 2020/0038673 describes such a cosmetic treatment apparatus.
Such apparatuses comprise an atmospheric-pressure plasma generation device configured to be able to generate atmospheric-pressure plasma from an electrical control signal.
Such cosmetic skin treatment apparatuses are generally configured to allow only one or two settings for the amount of plasma that can be instantaneously generated by the plasma generation device.
The possibilities for setting the amount of plasma that can be instantaneously generated are therefore limited. However, for some treatments, it can be preferable for an amount of plasma to be applied for which the apparatus does not provide a setting.
Furthermore, the setting is enabled by at least one push button or thumb wheel provided on the apparatus.
Thus, for such treatment apparatuses, the user selects the setting of the plasma generation device themselves by pressing the push button corresponding to this setting. However, the user is not always aware of the correct setting for their treatment. The use of such treatment apparatuses therefore can prove to be complex for the user.
Furthermore, the effectiveness of a setting for the amount of plasma in a treatment varies between users. Thus, a setting can be optimized for one user but not for other users.
The aim of the invention is to overcome these disadvantages.
In particular, the invention relates to a system comprising:
- an atmospheric-pressure plasma generation device;
- a control device configured to control the plasma generation device using a supply signal in accordance with a setting for performing a treatment on an element of interest of the skin, for example, an acne pimple;
- a processing unit configured to: o temporally monitor the results of the treatment on the element of interest; o define the setting of the supply signal as a function of the results of the temporal monitoring; o transmit the defined setting of the supply signal to the control device.
Setting the supply signal allows the plasma generation by the generation device to be set.
Preferably, setting the supply signal allows a total duration, a frequency and a power of this supply signal to be defined.
Such a system allows the setting of the supply signal to be adapted as a function of the results obtained by the treatment over time.
In particular, at the start of the treatment, an initial setting of the supply signal can be predefined or even randomly selected.
This initial setting may not be the most suitable setting for treating the element of interest of the skin of the user.
Thus, by adapting the setting during treatment as a function of the results that are obtained, it is possible to make the treatment more effective, and therefore reduce the treatment period for the element of interest.
Therefore, the supply signal is set as a function of the results that are obtained during the treatment on the skin of the user.
In an advantageous embodiment, the processing unit for performing the temporal monitoring is configured to: - obtain physiognomic data of the element of interest with which a temporal indication is associated; then
- store these physiognomic data and their temporal indication in a memory.
For example, the physiognomic data comprises dimensions of the element of interest and/or a level of inflammation of the element of interest and/or a level of sebum retention.
Preferably, the processing unit is configured to compare, each time physiognomic data is obtained, these latest obtained physiognomic data with previously obtained physiognomic data, for example, with the penultimate obtained physiognomic data, so as to compute a progression gradient for the treatment.
The progression gradient for the treatment allows the effectiveness of the setting that is used to be assessed.
Advantageously, the processing unit is configured to associate a progression gradient with each setting that is used, which progression gradient is computed after this setting has been used, and to store this setting and the associated progression gradient in the memory.
In an advantageous embodiment, the processing unit is configured to increase the setting of the supply signal when the progression gradient is below a predefined threshold.
In an advantageous embodiment, the processing unit is configured to define the setting associated with the highest progression gradient as the optimized setting.
The physiognomic data of the element of interest can be directly entered by the user. However, preferably the system also comprises an image acquisition device configured to acquire several images of the element of interest for temporally monitoring the results of the treatment on this element of interest. The processing unit is then configured to obtain said physiognomic data by extracting these physiognomic data from the acquired images.
Extracting physiognomic data from images of the element of interest makes it easier for the user to use the system. Indeed, the user does not have to enter these physiognomic data themselves, which can be difficult for the user to measure.
In an advantageous embodiment, the system comprises:
- a multifunction telephone comprising the image acquisition device, the processing unit and said memory; - a processing apparatus comprising the control device and the plasma generation device.
In an advantageous embodiment, the multifunction telephone comprises a transmitter configured to send the adapted setting of the supply signal to a receiver of the processing apparatus via a wireless transmission.
In an advantageous embodiment, the transmitter of the multifunction telephone is configured to send the adapted setting of the supply signal to the receiver of the treatment apparatus in accordance with the Bluetooth® communication standard.
The invention also relates to a method for setting a plasma generation device for treating an element of interest of the skin of a user, comprising:
- temporally monitoring the results of the treatment on the element of interest;
- setting the plasma generation device as a function of the results of the temporal monitoring.
In an advantageous embodiment, the temporal monitoring comprises obtaining physiognomic data of the element of interest with which a temporal indication is associated.
Advantageously, the physiognomic data comprises dimensions of the element of interest and/or an inflammation level of the element of interest and/or a level of sebum retention.
Preferably, the temporal monitoring comprises, each time physiognomic data is obtained, a computation of a progression gradient of the treatment on the basis of a comparison of the last physiognomic data obtained with previously obtained physiognomic data.
In an advantageous embodiment, each setting that is used is associated with a progression gradient computed after this setting has been used.
In an advantageous embodiment, the setting of the supply signal is increased when the progression gradient is below a predefined threshold.
Preferably, the method comprises defining an optimized setting, with the optimized setting being the setting associated with the highest progression gradient.
Advantageously, obtaining physiognomic data of the element of interest comprises:
- acquiring at least one image of the element of interest; and - extracting physiognomic data of the element of interest from said at least one acquired image.
The invention also relates to a method for setting a supply signal delivered by the control device of a system as described above, in particular for treating an element of interest of the skin of a user, the method comprising: o temporally monitoring the results of the treatment on the element of interest using the processing unit; o defining the setting of the supply signal as a function of the results of the temporal monitoring using the processing unit; o transmitting the defined setting of the supply signal to the control device using the processing unit.
The invention also relates to a computer program product comprising instructions which, when the program is executed by a processing unit, cause the processing unit to implement a method as described above.
Further advantages and features of the invention will become apparent with reference to the detailed description of embodiments, which are by no means limiting, and from the appended drawings, in which:
[F g 1],
[Fig 2] schematically show embodiments and implementations of the invention.
Figure 1 schematically shows a system SYS according to one embodiment of the invention.
The system SYS comprises a multifunction telephone TEL and a treatment apparatus APT, in this case cosmetic treatment.
Such a system SYS is configured to treat elements of interest of the skin of a user that are sensitive to atmospheric-pressure plasma.
By way of a non-limiting example, throughout the remainder of the description, such elements of interest are acne pimples ACN.
However, other elements of interest of the skin of a user can be contemplated. For example, the elements of interest of the skin can be rashes, pore size, micro-injuries or even dark spots.
The cosmetic treatment apparatus APT comprises an atmospheric-pressure plasma generation device DGP. The atmospheric-pressure plasma generation device DGP is configured to produce atmospheric-pressure plasma outside the apparatus APT from a supply signal SA.
In particular, the atmospheric-pressure plasma generation device DGP conventionally comprises a live electrode and a ground electrode, as well as a dielectric barrier placed against the live electrode. In an advantageous embodiment, the ground electrode is the biological surface on which the plasma generation device is applied. This biological surface thus acts as a floating ground electrode. An atmospheric- pressure plasma can be generated between these two electrodes. In particular, when the live electrode is powered relative to the ground electrode by the supply source, a plasma is generated from a plasma gas located between the electrodes. In an advantageous embodiment, the gas is the ambient air located between the dielectric barrier and the floating ground electrode (the treated biological surface). The plasma gas can contain at least one noble gas, such as helium or argon or neon.
The cosmetic treatment apparatus APT further comprises a control device DC configured to deliver the supply signal SA to the plasma generation device DGP.
In particular, the control device DC is adapted to deliver the supply signal SA from the energy stored in a battery BAT of the cosmetic treatment apparatus APT.
The supply signal SA delivered to the plasma generation device DGP allows the control device DC to control the amount of plasma instantaneously generated by this plasma generation device DGP.
Preferably, the supply signal SA is a pulse width modulation (PWM) signal. The amount of plasma that is instantaneously generated can then vary as a function of a duty cycle of the supply signal SA.
In addition, the control device DC has an input configured to receive a setting RSA of the supply signal. The control device DC is then configured to produce different supply signals SA depending on the setting RSA that it receives as input.
The setting of the supply signal allows a total duration, a frequency and a power of this supply signal to be defined.
For example, when the supply signal SA is a PWM signal, the control device DC can be configured to modify the duty cycle of the supply signal SA according to the setting RSA that it receives as input.
As an alternative embodiment, the control device DC can be configured to modify the voltage amplitude of the supply signal SA according to the setting RSA that it receives as input. More specifically, the apparatus APT has a receiver RE configured to be able to receive a setting RSA of the supply signal that is transmitted by a transmitter EM of the multifunction telephone. The receiver RE is electrically connected to the control device DC so as to be able to transmit the setting RSA of the supply signal thereto.
The setting RSA can be sent to the receiver RE by the transmitter EM using a wireless transmission RAD, for example, using the Bluetooth® communication standard.
The multifunction telephone TEL is configured to determine a setting RSA of the supply signal that is adapted to allow an amount of plasma to be generated that is suitable for treating an acne pimple of a user.
In particular, the multifunction telephone TEL comprises a processing unit UT. The processing unit UT can be a processor or a microprocessor, for example. The multifunction telephone TEL also comprises a memory MEM.
The processing unit UT is configured to temporally monitor the results of a treatment of an acne pimple ACN.
More specifically, the processing unit UT is configured to perform this temporal monitoring on the basis of images of the acne pimple ACN acquired over time during the treatment.
To this end, the multifunction telephone TEL comprises an image acquisition device DA. The image acquisition device DA conventionally can be a camera integrated in the multifunction telephone TEL.
The image acquisition device DA is therefore adapted to be able to acquire several images of an acne pimple over time during a treatment.
In particular, an image of the acne pimple can be acquired regularly, for example, on a daily basis.
The processing unit UT is configured to extract physiognomic data of the acne pimple from an acquired image of the acne pimple.
In particular, the physiognomic data of the acne pimple can be dimensions of the acne pimple and/or a level of inflammation and/or a level of sebum retention. The physiognomic data of the acne pimple can also include an indication of the position of the acne pimple on the face, and a date of appearance of the acne pimple.
The physiognomic data extracted from an image are associated with a temporal indication relating to an acquisition time of the image. For example, the temporal indication can be a date of acquisition of the image. The processing unit UT is also configured to store the extracted physiognomic data and its temporal indication in the memory MEM.
In order to temporally monitor the results of the treatment, the processing unit UT is configured to compare, each time physiognomic data is extracted, the physiognomic data extracted from the last acquired image with the physiognomic data extracted from a previously acquired image, for example, the penultimate acquired image.
On the basis of this comparison, the processing unit UT is configured to compute a progression gradient of the treatment on the basis of the comparison undertaken between the physiognomic data.
This progression gradient of the treatment allows the effectiveness of the setting that is used to be assessed.
Based on the computed progression gradient, the processing unit UT is configured to adapt a setting of the supply signal for the control device DC.
For example, the processing unit UT can be configured to adapt the setting of the supply signal on the basis of a comparison between the obtained progression gradient and a predefined threshold. As an alternative embodiment, the processing unit UT can be configured to adapt the setting of the supply signal on the basis of a comparison between the obtained progression gradient and a progression gradient computed after the acquisition of the penultimate image.
For example, the processing unit UT is configured to set a voltage amplitude of the supply signal delivered to the plasma generation device DGP. The processing unit can also set a frequency of the supply signal. Furthermore, the processing unit UT can also set a duty cycle of the supply signal, particularly when this supply signal is a PWM signal.
Once the setting of the supply signal is determined, the processing unit UT is configured to transmit this setting to the transmitter EM in order to send the setting to the processing apparatus.
In particular, when the setting is received by the receiver RE of the processing apparatus, the setting is transmitted to the control device DC. The control device DC is then configured to supply the plasma generation device DGP from a supply signal generated according to the received setting.
Furthermore, the processing unit UT is configured to store the progression gradients that are obtained for the various selected settings in the memory MEM. On the basis of the various progression gradients stored in the memory MEM, the processing unit UT is configured to define an optimized setting of the supply signal. The optimized setting is the setting for which the progression gradient obtained from this setting is the highest.
Figure 2 describes a method for setting a supply signal delivered by the control device DC of the system described above for treating an acne pimple of a user.
The method comprises a first step 20, in which a first image of the acne pimple is acquired at the start of the treatment by the image acquisition device.
Subsequently, the method comprises a step 21, in which the processing unit UT extracts physiognomic data of the acne pimple from the acquired first image. This information can be pimple dimensions, a level of inflammation level and a level of sebum retention. A temporal indication of the acquisition time of the image is associated with these physiognomic data. The physiognomic data and their temporal indications are stored in the memory MEM.
Then, the method comprises a step 22, in which the processing unit UT defines an initial setting of the supply signal. This setting can be a predefined setting or can be randomly selected.
Subsequently, the method comprises a series of steps 23 to 29, which it regularly repeats in order to adapt the setting of the supply signal during the treatment.
In particular, the method comprises temporal monitoring ST of the treatment of the acne pimple on the basis of the images acquired at various times of the treatment, for example, every day.
Thus, the temporal monitoring ST comprises a step 23, in which the image acquisition device acquires a new image.
The temporal monitoring comprises a step 24, in which the processing unit UT obtains the image acquired by the image acquisition device. This image thus has been acquired at a given time of the treatment.
The temporal monitoring subsequently comprises a step 25, in which the processing unit UT extracts new physiognomic data of the acne pimple from the image acquired in step 23. A temporal indication of the time of image acquisition is associated with these new physiognomic data. The new physiognomic data and their temporal indications are stored in the memory MEM. Next, the temporal monitoring comprises a step 26, in which the processing unit UT compares the physiognomic data extracted from the last acquired image with the physiognomic data extracted from the penultimate acquired image.
This comparison allows the processing unit UT to compute a progression gradient of the treatment. This progression gradient can be computed from a difference between the levels of inflammation extracted from the two images and/or a difference between the levels of sebum retention extracted from the two images and/or a difference between the dimensions of the pimple extracted from the two images.
The progression gradient of the treatment allows the effectiveness of a used setting to be assessed.
The processing unit UT then uses this progression gradient to adapt the setting of the supply signal.
The setting of the supply signal allows a total duration, a frequency and a power of this supply signal to be defined.
In particular, in step 27, the processing unit UT compares the progression gradient computed in step 26 to a predefined threshold or even to a previous progression gradient computed after the acquisition of the penultimate image.
Depending on the result of this comparison, the processing unit UT increases, reduces or maintains the setting of the supply signal.
For example, if the progression gradient is above the threshold or the previous progression gradient, the processing unit UT can decide to maintain the setting of the supply signal or even to decrease it.
Furthermore, if the progression gradient is below the threshold or the previous progression gradient, the processing unit UT can decide to increase the setting of the supply signal.
Then, in step 28, the processing unit UT transmits the adapted setting, via the transmitter EM, to the treatment device, and more specifically to the control device DC, by means of the receiver RE.
Subsequently, the processing unit assesses, in step 29, whether or not the treatment of the acne pimple has been completed. If the treatment is not complete, steps 23 to 29 are repeated.
At the end of the treatment, the method can comprise a step 30, in which the processing unit UT defines an optimized setting of the supply signal. This optimized setting is the setting that allowed the highest progression gradient to be obtained during the treatment.
This optimized setting of the supply signal then can be used at the start of future treatments of other acne pimples of the user. Of course, the present invention has the potential for various alternative embodiments and modifications that will become apparent to a person skilled in the art. For example, the processing unit UT can be configured to perform temporal monitoring of several acne pimples of the user. Indeed, the image acquisition device can be used to take an image of several acne pimples, in particular on the face of the user. The processing unit UT then can be configured to identify a position on the face for each acne pimple. The processing unit UT thus can, for each acne pimple, associate and then store an identifier of the acne pimple, its position and its physiognomic data in the memory MEM. The processing unit UT thus can temporally monitor each pimple separately on the basis of this information that is stored in the memory. Furthermore, the present invention is compatible with the invention that is the subject matter of the French patent application filed under No. 2009662 and/or with the invention that is the subject matter of the French patent application filed under No. 2009661.

Claims

1. System comprising:
- an atmospheric-pressure plasma generation device (DGP);
- a control device (DC) configured to control the plasma generation device (DGP) using a supply signal in accordance with a setting for performing a treatment on an element of interest of the skin;
- a processing unit (UT) configured to: o temporally monitor the results of the treatment on the element of interest; o define the setting of the supply signal as a function of the results of the temporal monitoring; o transmit the defined setting of the supply signal to the control device (DC).
2. System according to Claim 1, wherein the processing unit (UT) for performing the temporal monitoring is configured to:
- obtain physiognomic data of the element of interest with which a temporal indication is associated; then
- store these physiognomic data and their temporal indications in a memory (MEM).
3. System according to Claim 2, wherein the physiognomic data comprises dimensions of the element of interest and/or a level of inflammation of the element of interest and/or a level of sebum retention.
4. System according to any one of Claims 2 or 3, wherein the processing unit is configured to compare, each time physiognomic data is obtained, said obtained physiognomic data with previously obtained physiognomic data so as to compute a progression gradient of the treatment.
5. System according to Claim 4, wherein the processing unit (UT) is configured to associate a progression gradient with each setting that is used, which progression gradient is computed after this setting has been used, and to store this setting and the associated progression gradient in the memory (MEM).
6. System according to any one of Claims 4 or 5, wherein the processing unit (UT) is configured to increase the setting of the supply signal when the progression gradient is below a predefined threshold.
7. System according to any one of Claims 5 or 6, wherein the processing unit (UT) is configured to define the setting associated with the highest progression gradient as the optimized setting.
8. System according to any of Claims 1 to 7, further comprising an image acquisition device (DA) configured to acquire a plurality of images of the element of interest for temporally monitoring the results of the treatment on this element of interest, and wherein the processing unit (UT) is configured to obtain said physiognomic data by extracting these physiognomic data from the acquired images.
9. System according to Claims 2 and 8, comprising:
- a multifunction telephone (TEL) comprising the image acquisition device (DA), the processing unit (UT) and said memory (MEM);
- a processing apparatus (APT) comprising the control device (DC) and the plasma generation device (DGP).
10. System according to Claim 9, wherein the multifunction telephone (TEL) comprises a transmitter (EM) configured to send the adapted setting of the supply signal to a receiver (RE) of the processing apparatus (APT) via a wireless transmission.
11. System according to Claim 10, wherein the transmitter (EM) of the multifunction telephone (TEL) is configured to send the adapted setting of the supply signal to the receiver (RE) of the processing apparatus (APT) in accordance with the Bluetooth® communication standard.
12. System according to Claims 1 to 11, wherein setting the supply signal allows a total duration, a frequency and a power of the supply signal to be defined.
13. Method for setting a plasma generation device for treating an element of interest of the skin of a user, comprising:
- temporally monitoring the results of the treatment on the element of interest;
- setting the plasma generation device as a function of the results of the temporal monitoring.
14. Method according to Claim 13, wherein the temporal monitoring comprises obtaining physiognomic data of the element of interest with which a temporal indication is associated.
15. Method according to Claim 14, wherein the physiognomic data comprises dimensions of the element of interest and/or a level of inflammation of the element of interest and/or a level of sebum retention. 14
16. Method according to any one of Claims 14 or 15, wherein the temporal monitoring comprises, each time physiognomic data is obtained, computing a progression gradient of the treatment on the basis of a comparison of the last obtained physiognomic data with previously obtained physiognomic data.
17. Method according to Claim 16, wherein each setting that is used is associated with a progression gradient computed after this setting has been used.
18. Method according to any one of Claims 16 or 17, wherein the setting of the supply signal is increased when the progression gradient is below a predefined threshold.
19. Method according to any one of Claims 17 or 18, comprising defining an optimized setting, the optimized setting being the setting associated with the highest progression gradient.
20. Method according to any of Claims 13 to 19, wherein obtaining physiognomic data of the element of interest comprises:
- acquiring at least one image of the element of interest; and
- extracting physiognomic data of the element of interest from said at least one acquired image.
21. Method for setting a supply signal delivered by the control device (DC) of a system according to any of Claims 1 to 12, in particular for processing an element of interest of the skin of a user, the method comprising: o temporally monitoring the results of the treatment on the element of interest using the processing unit (UT); o defining the setting of the supply signal as a function of the results of the temporal monitoring using the processing unit (UT); o transmitting the defined setting of the supply signal to the control device (DC) using the processing unit (UT).
22. Computer program product comprising instructions which, when the program is executed by a processing unit, cause the processing unit to implement a method according to any of claims 13 to 21.
PCT/EP2022/050234 2021-01-21 2022-01-07 Monitoring of treatment history and the adaptation thereof WO2022157015A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2100568A FR3118882B1 (en) 2021-01-21 2021-01-21 TREATMENT HISTORY MONITORING AND ITS ADAPTATION
FRFR2100568 2021-01-21

Publications (1)

Publication Number Publication Date
WO2022157015A1 true WO2022157015A1 (en) 2022-07-28

Family

ID=77021368

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2022/050234 WO2022157015A1 (en) 2021-01-21 2022-01-07 Monitoring of treatment history and the adaptation thereof

Country Status (2)

Country Link
FR (1) FR3118882B1 (en)
WO (1) WO2022157015A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2009661A1 (en) 1968-05-30 1970-02-06 Argus Chem
FR2009662A1 (en) 1968-05-30 1970-02-06 Casotti Ettore
KR101929360B1 (en) * 2017-10-13 2018-12-19 진석 Skin care apparatus for integrating skin diagnosis and treatment
US20190053365A1 (en) * 2016-04-18 2019-02-14 Airbio Inc. Beauty care device using plasma
US20190387973A1 (en) * 2018-06-22 2019-12-26 Avava, Inc. Feedback detection for a treatment device
US20200038673A1 (en) 2018-07-31 2020-02-06 L'oreal Cold plasma generating devices, systems, and methods
WO2020091086A1 (en) * 2018-10-29 2020-05-07 주식회사 릴리커버 Skin diagnosis method, skin diagnosis device, and recording medium

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2009661A1 (en) 1968-05-30 1970-02-06 Argus Chem
FR2009662A1 (en) 1968-05-30 1970-02-06 Casotti Ettore
US20190053365A1 (en) * 2016-04-18 2019-02-14 Airbio Inc. Beauty care device using plasma
KR101929360B1 (en) * 2017-10-13 2018-12-19 진석 Skin care apparatus for integrating skin diagnosis and treatment
US20190387973A1 (en) * 2018-06-22 2019-12-26 Avava, Inc. Feedback detection for a treatment device
US20200038673A1 (en) 2018-07-31 2020-02-06 L'oreal Cold plasma generating devices, systems, and methods
WO2020091086A1 (en) * 2018-10-29 2020-05-07 주식회사 릴리커버 Skin diagnosis method, skin diagnosis device, and recording medium

Also Published As

Publication number Publication date
FR3118882A1 (en) 2022-07-22
FR3118882B1 (en) 2023-05-26

Similar Documents

Publication Publication Date Title
US11794019B2 (en) Methods and systems for reducing interference in stimulation treatment
JP6076368B2 (en) Skin treatment equipment
US9333346B1 (en) Multi-mode microcurrent stimulus system with safety circuitry and related methods
US6766199B2 (en) Skin/hair treatment method and system
EP2768579B1 (en) Electrical stimulation device having remote access
CN110322957A (en) A kind of real time remote magnetotherapy system and real time remote magnetotherapy method
CN111603673A (en) Adjusting method of neck massager and neck massager
CN211383459U (en) Skin management device
US20170128724A1 (en) Optimization of application of current
JP2009519738A (en) Skin stimulation device, method for detecting skin stimulation position, and computer program
JP2018132890A (en) Control apparatus, beauty treatment device, beauty treatment support system, and program
WO2004069129A1 (en) Medical treatment system for stimulating spots on the body suitable for acupuncture
WO2022157015A1 (en) Monitoring of treatment history and the adaptation thereof
KR102106964B1 (en) Portable low-frequency electric stimulation apparatus and method for controlling the same
US20170043159A1 (en) Closed-loop stimulating apparatus and stimulating method thereof
JP2713149B2 (en) Wireless in-vivo embedded receiver control system
CN114243926B (en) Output current control method, device, system and storage medium
US20230405167A1 (en) Apparatus for the treatment of a biological surface using atmospheric- pressure plasma
CN113426008A (en) Massage control method, massage device, and computer-readable storage medium
CN114272516A (en) Output current control method, device, system and storage medium
CN112870565A (en) Repair system applied to myofascial and ligament external non-invasive repair
CN115957444A (en) Tremor massage control method and device, massage instrument, electronic device and storage medium
WO2003018118A1 (en) Adaptive electrostimulator
JP2005130876A (en) Electrostimulator
FR2855060A1 (en) Pain-relieving device for degenerative muscular disease e.g. rheumatism, treatment, has solar electrical supply source with regulator and battery, and audio vibration mechanism emitting pulses using coil to switch MOSFETs to be on/off

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22700011

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22700011

Country of ref document: EP

Kind code of ref document: A1